The role of adjuvant chemotherapy in surgical stages I-II serous and clear cell carcinomas and carcinosarcoma of the endometrium: A collaborative study

International Journal of Gynecological Cancer

Volumn 21, Issue 2, 2011, Pages 332-336

  Vandenput, Ingrid ^a   Trovik, Jone ^b,c   Vergote, Ignace ^a   Moerman, Philippe ^a   Leunen, Karin ^a   Berteloot, Patrick ^a   Neven, Patrick ^a   Salvesen, Helga ^b,c   Amant, Frédéric ^a,d  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF BERGEN   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Adjuvant; Carcinosarcoma; Chemotherapy; Serous; Surgery

Indexed keywords

ALTRETAMINE; CARBOPLATIN; CISPLATIN; DOXORUBICIN; EPIRUBICIN; PACLITAXEL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOSARCOMA; CLEAR CELL CARCINOMA; CLINICAL ASSESSMENT; CONTROLLED STUDY; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOSARCOMA; ENDOMETRIUM CLEAR CELL CARCINOMA; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; OMENTECTOMY; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SALPINGOOOPHORECTOMY; TREATMENT DURATION; TREATMENT OUTCOME;

ADENOCARCINOMA, CLEAR CELL; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CARCINOSARCOMA; CHEMOTHERAPY, ADJUVANT; CYSTADENOCARCINOMA, SEROUS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 79956078774     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e3182094ded     Document Type: Article

References (25)

1. Amant F, Moerman P, Neven P, et al. Endometrial cancer. Lancet. 2005;366:591-605.
2. Bitterman P, Chun B, Kurman RJ. The significance of epithelial differentiation in mixed mesodermal tumors of the uterus. Am J Surg Pathol. 1990;14:317-328.
3. Silverberg SG, Major FJ, Blessing JA, et al. Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A Gynecological Oncology Group pathologic study of 203 cases. Int J Gynecol Pathol. 1990;9:1-19. (Pubitemid 20067452)
4. Sreenan J, Hart W. Carcinosarcomas of the female genital tract. A pathologic study of 29 metastatic tumors. Am J Surg Pathol. 1995;19:666-674.
5. Amant F, Cadron I, Fuso L, et al. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high risk epithelial endometrial cancer. Gynecol Oncol. 2005;98:274-280. (Pubitemid 41019116)
6. Slomovitz B, Burke T, Eifel P, et al. Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases. Gynecol Oncol. 2003;91:463-469. (Pubitemid 38388137)
7. Huh W, Powell M, Leath C 3rd, et al. Uterine papillary serous carcinoma: comparisons of outcomes in surgical stage I patients with and without adjuvant therapy. Gynecol Oncol. 2003;91: 470-475. (Pubitemid 38388138)
8. Fader A, Boruta D, Olawaiye A, et al. Uterine papillary serous carcinoma: epidemiology, pathogenesis and management. Curr Opin Obstet Gynecol. 2010;22:21-29.
9. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix and endometrium. Int J Gynaecol Obstet. 2009;105: 103-104.
10. Cragun J, Havrilesky L, Calingaert B, et al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol. 2005;23:3668-3675.
11. Gehrig PA, Van Le L, Fowler WC Jr. The role of omentectomy during the surgical staging of uterine serous carcinoma. Int J Gynecol Cancer. 2003;13:212-215. (Pubitemid 37055480)
12. Elit L, Kwon J, Bentley J, et al. Optimal management for surgical stage I serous cancer of the uterus. Gynecol Oncol. 2004;92:240-246. (Pubitemid 38147398)
13. Kelly M, O'Malley D, Hui P, et al. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy. Gynecol Oncol. 2005;98:353-359. (Pubitemid 41169144)
14. Dietrich CS 3rd, Modesitt SC, DePriest PD, et al. The efficacy of adjuvant platinum-based chemotherapy in stage I uterine papillary serous carcinoma (UPSC). Gynecol Oncol. 2005;99: 557-563. (Pubitemid 41686536)
15. Thomas M, Mariani A, Cliby W, et al. Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma. Gynecol Oncol. 2007;107: 186-189. (Pubitemid 47575712)
16. Fader A, Starks D, Gehrig P, et al. An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC). Gynecol Oncol. 2009;115:244-248.
17. Alektiar KM, Makker V, Abu-Rustum NR, et al. Concurrent carboplatin/paclitaxel and intravaginal radiation in surgical stage I-II serous endometrial cancer. Gynecol Oncol. 2009;112:142-145.
18. Grice J, Ek M, Greer B, et al. Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients. Gynecol Oncol. 1998;69:69-73. (Pubitemid 28201674)
19. Bristow R, Asrari F, Trimble E, et al. Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (stage I-III) disease. Gynecol Oncol. 2001;81: 279-286. (Pubitemid 32424175)
20. Havrilesky L, Secord A, Bae-Jump V, et al. Outcomes in surgical stage I papillary serous carcinoma. Gynecol Oncol. 2007;105:677-682. (Pubitemid 46734192)
21. Kwon JS, Abrams J, Sugimoto A, et al. Is adjuvant therapy necessary for stage IA and IB uterine papillary serous carcinoma and clear cell carcinoma after surgical staging? Int J Gynecol Cancer. 2008;18:820-824. (Pubitemid 352020171)
22. Randall M, Filiaci V, Muss H, et al; Gynecologic Oncology Group Study. Randomized phase III trial of whole-abdominal irradiation versus doxorubicin and cisplatin chemotherapy in advanced endometrial carcinoma: a Gynecologic Oncology Group study. J Clin Oncol. 2006;24:36-44. (Pubitemid 46630491)
23. Hogberg T, Signorelli M, Freire de Oliveira C, et al. Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer-results from two randomised studies. Eur J Cancer. 2010;46:2422-2431.
24. Omura G, Blessing J, Major F, et al. A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study. J Clin Oncol. 1985;3:1240-1245. (Pubitemid 15226529)
25. Reed N, Mangioni C, Malmstrom H, et al. First results of a randomized trial comparing radiotherapy versus observation postoperatively in patients with uterine sarcomas. An EORTC-GCG study. Int J Gynecol Cancer. 2003;13S:4.